Core Viewpoint - China Resources Medical (01515) reported a decline in revenue and profit for the six months ending June 30, 2025, indicating challenges in the healthcare sector, particularly in hospital operations [1] Financial Performance - Revenue for the period was 4.525 billion RMB, a decrease of 9.07% year-on-year [1] - Shareholder profit attributable to the company was 340 million RMB, down 21.76% compared to the previous year [1] - Basic earnings per share were 0.27 RMB, with an interim dividend proposed at 0.05 RMB per share [1] Hospital Operations - The hospital business segment generated revenue of 4.259 billion RMB, reflecting a 7.4% decline year-on-year [1] - Outpatient and emergency visits increased by 1.0%, while inpatient visits decreased by 3.9% [1] - Due to a decrease in average medical insurance costs, average revenue per outpatient and inpatient visit fell by 5.8% [1] Operational Scale - As of June 30, 2025, the group managed and operated 103 medical institutions across 10 provinces and cities in China [1] - The total outpatient visits and inpatient admissions for the group's own hospitals were approximately 5.1 million and 270,000, respectively, showing a 1.0% increase and a 3.9% decrease year-on-year [1]
华润医疗发布中期业绩 股东应占溢利3.4亿元 同比减少21.76%